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sCPII and sPIIANP only appeared to be correlated (R = 0.29;
p = 0.002). Between synthesis and degradation markers, only
sCPII and uCTX-II appeared to be weakly correlated (R = 0.18;
p = 0.016). The ratio of uCTX-II or uTIINE to sCPII enhanced the
differences between OA patients and control subjects.
Conclusions: In the present study, the combination of both syn-
thesis and degradation markers of type II collagen appeared to
better differentiate OA patients from healthy volunteers. However,
each of these markers may reflect the activity of different set of
enzymes that may play a critical role at different stages of the
disease, and therefore evaluation of the full panel of biomarkers
may be required to understand disease progression and potential
therapies.
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Purpose: In classic collagen-induced arthritis (CIA) models, the
disease is induced by injection of type II collagen. Such murine
CIA models are widely used to study the pathology of rheumatoid
arthritis (RA) and to evaluate the effects of potential anti-arthitic
drugs. Recently, a rapid murine model of RA employing mono-
clonal antibodies against type II collagen was developed which
reduces the timeline compared to classic CIA experiments.
The objective of the present study was to characterize the clinical,
biochemical, 3-D microstructural and histopathological features
in BALB/c mice injected with anti-type II collagen antibodies.
Methods: 48 eight-week-old mice were randomly assigned to
6 groups with 8 mice in each group: One control group (non-
diseased), four CIA groups and one CIA + dexamethasone
(Dex) group. CIA was induced by intravenous injection of 2 or 4
mg/mouse Arthrogen-CIA® anti-type II collagen antibodies (mAB)
on day 1 followed by 25 or 50 μg/mouse lipopolysaccharide (LPS)
on day 3. Additionally, the treated group induced with 2 mg mAB
and 50 μg LPS received daily doses of Dex (0.5 mg/kg) by
gavage following onset of the disease (day 5) until termination of
the experiment (day 15).
Paw inflammation (redness and swelling) were evaluated daily
for all animals.
Circulating levels of matrix metalloproteinase-derived fragments
of collagen type II were measured at study termination by serum
CTX-II. Structural changes were evaluated by histopathology and
micro-CT scanning of the hindpaws.
Results: On the 5th day after induction of disease all CIA mice
had significantly higher paw inflammation scores than the control
group (p<0.05). Hereafter the treated group received daily doses
of Dex, and at study termination the paw inflammation score for
this group had decreased to the level of the control group and
was significantly different from the CIA group (p<0.05).
The levels of MMP-derived collagen type II fragments in serum at
study termination were found to correlate to the paw inflammation
scores (p<0.001). As shown in Figure 1, the serum levels of
collagen type II fragments for the CIA group induced by 2
mg mAB and 50 μg LPS (B) were significantly increased at
termination compared to the non-diseased control group (A)
(p=0.027). Daily doses of Dex were able to suppress the level of
these fragments in the treated group (C) compared to the CIA
group (B) (p<0.0001).
Histopathology demonstrated a noticeable reduction in inflamma-
tion, cartilage damage, bone resorption and osteophyte formation
in the group treated with Dex compared to the CIA groups.
Micro-CT analyses of the hindpaws showed a marked increase
in the extent of new bone formation and a slight increase in
bone resorption in the CIA groups compared to the non-diseased
control group and demonstrated the complete prevention of these
changes in the treated group.
Fig. 1. Levels of MMP-derived fragments of collagen type II in serum at study
termination. A) Non-diseased control group. B) CIA group. C) CIA + dexametha-
sone group.
Conclusions: Intravenous injection of 2 mg mAB followed by
50 μg of LPS induced a persistent disease in the BALB/c mice
with an incidence of 100%. Moreover, treatment with 0.5 mg/kg
dexamethasone relieved the mice from all of the assessed dis-
ease parameters. The anti-inflammatory action of dexametha-
sone was reflected in a dramatic decrease in serum levels of
matrix metalloproteinase-derived fragments of collagen type II.
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Purpose: The Osteoarthritis Initiative (OAI) is targeted at iden-
tifying biomarkers for development and progression of symp-
tomatic knee OA. Magnetic resonance (MR) imaging can pro-
vide three-dimensional metrics of cartilage morphology, with fast
low angle shot (FLASH) and double echo steady state (DESS)
sequences with water excitation having been validated in this
context at 3 Tesla. The purpose of this pilot is to compare the
sensitivity of the two sequences to detect change in cartilage
volume over 2 years.
Methods: 9 participants with mild to moderate OA were exam-
ined twice at baseline (BL), twice at 1 year (Y1), and once at
2 years (Y2). A double oblique coronal FLASH with 1.5 mm
slice thickness and a sagittal DESS with 0.7 mm slice thickness
were acquired. Coronal multiplanar reformats (MPR) from the
DESS were obtained at 1.5 mm slice thickness. Femorotibial
joint cartilage plates (medial and lateral tibia = MT/LT, central
medial/lateral central femoral condyles = cMF/cLF) were exam-
ined using FLASH, DESS and MPR, and the patella (P) and
posterior medial and lateral femoral condyles (pMF/pLF) with
the sagittal DESS. Proprietary software (Chondrometrics GmbH,
Ainring, Germany) was used for image analysis. Knees were
analyzed in quadruples (Y1) and pairs (Y2) with blinding to the
order of acquisition. In the femorotibial compartment, aggregate
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values of MT/cMF and of LT/cLF were computed and their cor-
responding changes with time. 6 of the 9 participants underwent
radiography: 2 had KL grade 1, 3 KLG 2, and 1 KLG 3.
Results: In the femorotibial joint, the root mean square coeffi-
cient of variation (RMS CV%) for cartilage volume ranged from
1.1% (FLASH at LT) to 3.5% (DESS at MT). The average RMS
CV% in all femorotibial plates was 1.8% for FLASH and 3.0%
for the MPR. Changes in MT between BL and Y2 were -2.3%
for FLASH, -2.3% for DESS, and -0.7% for MPR. Corresponding
changes were -1.6%/-3.6%/+0.6% for cMF, -3.4%/-5.4%/-2.0%
for LT, and +0.4/-0.1%/+1.0% for cLF (FLASH/DESS/MPR). The
average volume loss in these 4 plates was -1.7% for FLASH,
-2.9% for DESS, and -0.3% for the MPR. Cartilage volume
change was -2.6% in P, -0.6% in pMF, and -4.0% in pLF (DESS).
Only the combined change in MT/cMF with DESS at Y2 reached
statistical significance (p = 0.046).
Conclusions: FLASH and DESS displayed adequate repro-
ducibility in a paired analysis study design with blinding to time
point of acquisition. Cartilage volume change seen over 2 years
was relatively little in this small sample (n = 9) with mild to mod-
erate OA. As a trend, 0.7mm DESS showed higher sensitivity
than 1.5mm FLASH, and 1.5mm FLASH higher sensitivity than
1.5mm MPR DESS, but this needs to be confirmed in larger
samples.
Acknowledgment: Partially funded by NIAMS (contracts N01-
AR-2-2261, N01-AR-2-2262 and N01-AR-2-2258).
P105
ANGIOGENSIS MARKERS IN OSTEONECROSIS OF THE
KNEE
Y. Yamaguchi, R. Takeuchi, T. Shirai, Y. Umemoto, K. Maeda,
Y. Yamazaki, R. Ito, T. Saito
Yokohama City University, Yokohama, Japan
Purpose: Spontaneous osteonecrosis (ON) of the femoral
condyle has been recognized since 1968, when it was first
described by Ahlbäck et al. In its early stages, ON is primar-
ily a disease of subchondral bone and the overlying articular
cartilage remains intact. When its advanced stages, the knee
joint was collapsed and sift the osteoarthritis. Among several
proposed causes of the disease, vascular or traumatic factors
have been the main candidates. Lotke et al emphasized mi-
crofractures within osteoporotic subchondral bone as a possible
etiologic mechanism.
During bone regeneration, both sufficient blood supply by stim-
ulation of angiogenesis and well-regulated remodeling of bone
matrix are prerequisites for well-organized bone formation.
We hypothesize that angiogenesis is actively developed around
the necrotic lesion of patients with ON. To prove the validity we
investigated variety of anigiogenic marker in the joint fluid and
synovial membrane and necrotic subchondral bone of ON and
OA.
Methods: From February 2003 to November 2006, synovial fluid
samples which were obtained from 13 knees of 13 patients (11
women and 2 men) with ON were enrolled in this study. And all
of them had ON of the medial femoral condyle and had been
underwent surgical treatment.
As a control, we studied 22 knees of 18 patients (13 women and
5 men) who had been diagnosed as having OA of the medial
compartment and who underwent surgical treatment.
Patients with ON were matched with OA by age, gender, height,
weight and body mass index. All patients received informed
consent.
The levels of angiogenin, VEGF, IL-6 and MMP-3 were measured
using the ELISA technique. We confirmed that the subchondral
necrotic lesion were exposed in confirmed in operation, and
compared with the results of joint fluid analysis.
Synovial membrane and subchondral bone which including
necrotic lesion were obtained from patient with ON at the time of
operation with informed consent. VEGF and angiogenin expres-
sion in these tissue was investigated with immunohisutchemistry.
Mann-Whitney U tests were done to determine if differences of
each angiogenesis markers were significant between ON and OA
and between exposed subchondral necrotic lesion or not. The
correlation between the angiogenin and VEGF were analyzed
statistically according to a simple regression correlation. A p
value less than 0.05 was regarded as statistically significant.
Results: The mean ± SD levels of MMP-3 were 1397.2±513.9
ng/ml in ON and 1140.5±434.0 ng/ml in OA. The mean ± SD lev-
els of IL-6 were 2105.7±1071.8 pg/ml in ON and 1959.1±1112.4
pg/ml in OA. The mean ± SD levels of VEGF were 957.7±692.8
pg/ml in ON and 1955.8±1256.8 pg/ml in OA. The mean ± SD
levels of angiogenin were 121072±35053.3 pg/ml in ON and
100387±25934.1 pg/ml in OA. Angiogenin levels in ON were
significantly higher than in OA (p>0.030), and VEGF levels in
OA were significantly higher than in ON (P>0.015). Angiogenin
levels correlated with VEGF levels both in ON (r=0.588) and
OA (r=0.610). In ON, the mean± SD levels of angiogenin were
84861±12855 pg/ml in the group in which subchondral lesion
was not exposure and 131935 ± 32146 pg/ml in the group in
which was exposure. Angiogenin levels of the exposure group
were significantly higher than that of the non-exposure group.
In histchemical studies, angiogenin (green) and VEGF (co-
expressing cells were detected in synovial membrane and sub-
chondral bone. In subchondral bone, angiogenin and VEGF co
expressing cells was detected deep layer of the necrotic lesion.
Conclusions: The results of the present study suggest that the
angiogenesis via with angiogenin is more active in patient with
ON than that with OA. And there is possibility that in the knee of
patient with ON, angiogenesis via with angiogenin occur around
the necrotic lesion to repair this.
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Purpose: Validated biomarkers would be of value in defining
OA disease severity, progression, and therapeutic response. Al-
though identification of a single marker to assess OA natural his-
tory and severity would be ideal, a panel of biomarkers defining
matrix synthesis/degradation, and inflammation may be required.
Factors impacting biomarker correlations include not only stage
of structural damage but also disease duration. Eleven biomark-
ers targeted to different responses associated with matrix syn-
thesis and degradation, and joint inflammation were evaluated
in a patient cohort from a study of Genetics of Generalized
Osteoarthritis (GOGO).
Methods: Biomarker correlations were computed from data of
98 subjects, mean age 65 yrs (range 59-71), median duration
14 yrs, in all of whom x-rays of knees, and hips were available.
Kellgren-Lawrence (K-L) grade (0-IV) and Joint Space Narrowing
(JSN) (0-3), osteophyte severity (0-3), and sclerosis (0,1) were
determined by an experienced musculoskeletal radiologist. Using
standardized MRI-derived joint cartilage volumes, Total Quantita-
tive Osteoarthritis Load (TQOL) scores were computed related to
knee and hip OA. Biomarkers included serum Bone Sialoprotein
